Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45920 | 22087157 | Hepat Mon | Liver complications in celiac disease. | 2011 | Details |
| A45921 | 22075260 | J Hepatol | Focus. An emerging conceptual scaffold for NASH. | 2011 | Details |
| A45922 | 22053380 | Zhonghua Gan Zang Bing Za Zhi | [Effect of microbial pharmaceutics on the function of NKT cells in rats with non-alcoholic steatohepatitis]. | 2011 | Details |
| A45923 | 22046940 | Am Fam Physician | Causes and evaluation of mildly elevated liver transaminase levels. | 2011 | Details |
| A45924 | 22045668 | Hepatology | Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development. | 2011 | Details |
| A45925 | 22045667 | Hepatology | Pentoxifylline for steatohepatitis: magic bullet or smoking gun? | 2011 | Details |
| A45926 | 22027652 | Pharmacogenet Genomics | Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition. | 2011 | Details |
| A45927 | 22027575 | J Hepatol | Hepatitis B virus infection and fatty liver in the general population. | 2011 | Details |
| A45928 | 22018903 | Hum Pathol | The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. | 2011 | Details |
| A45929 | 22005190 | Adv Cardiol | Metabolic disorders associated with obstructive sleep apnea in adults. | 2011 | Details |
| A45930 | 21997755 | Dig Dis Sci | The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). | 2011 | Details |
| A45931 | 21994857 | Int J Hepatol | Hepatobiliary disorders in celiac disease: an update. | 2010 | Details |
| A45932 | 21985780 | Ann Nutr Metab | Low-carbohydrate diets: a matter of love or hate. | 2011 | Details |
| A45933 | 21972445 | Zhonghua Gan Zang Bing Za Zhi | [The joint pathway of metabolism and inflammation in nonalcoholic fatty liver disease]. | 2011 | Details |
| A45934 | 21970998 | J Pediatr Gastroenterol Nutr | Duchenne and Becker muscular dystrophy presenting as nonalcoholic fatty liver disease. | 2011 | Details |
| A45935 | 21969091 | Hepatology | Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis. | 2012 | Details |
| A45936 | 21964177 | Mayo Clin Proc | 73-year-old man with increasing abdominal girth and dyspnea. | 2011 | Details |
| A45937 | 21956705 | Hepatology | Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease? | 2011 | Details |
| A45938 | 21953015 | Hepatology | Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials? | 2011 | Details |
| A45939 | 21947647 | Nutr Clin Pract | Vitamin E for nonalcoholic fatty liver disease. | 2011 | Details |
| A45940 | 21946021 | J Hepatol | The use of acoustic radiation force-based shear stiffness in non-alcoholic fatty liver disease. | 2011 | Details |
| A45941 | 21925128 | J Hepatol | Chronic intermittent hypoxia: a breath of fresh air in the understanding of NAFLD pathogenesis. | 2011 | Details |
| A45942 | 21941075 | J Postgrad Med | Nonalcoholic fatty liver disease in south India. | 2012 | Details |
| A45943 | 21933215 | Aliment Pharmacol Ther | Hyperuricemia in non-alcoholic fatty liver disease. | 2011 | Details |
| A45944 | 21917277 | Metabolism | Adiponectin levels in nonalcoholic fatty liver disease. | 2011 | Details |
| A45945 | 21911903 | Ann Hepatol | Citrus auraptene: a potential multifunctional therapeutic agent for nonalcoholic fatty liver disease. | 2011 | Details |
| A45946 | 21908766 | Toxicol Sci | 3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity. | 2011 | Details |
| A45947 | 21904679 | Biochem Res Int | The increased activity of liver lysosomal lipase in nonalcoholic Fatty liver disease contributes to the development of hepatic insulin resistance. | 2011 | Details |
| A45948 | 21901286 | Obes Surg | Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. | 2012 | Details |
| A45949 | 21898508 | Hepatology | Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. | 2012 | Details |
| A45950 | 21898494 | Hepatology | Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? | 2011 | Details |
| A45951 | 21893033 | Biochem Biophys Res Commun | Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism. | 2011 | Details |
| A45952 | 21888877 | J Hepatol | C reactive protein levels in non-alcoholic fatty liver disease. | 2011 | Details |
| A45953 | 21886053 | South Med J | A paradigm shift in the outpatient approach to liver function tests. | 2011 | Details |
| A45954 | 21885692 | Cleve Clin J Med | Hepatic encephalopathy: suspect it early in patients with cirrhosis. | 2011 | Details |
| A45955 | 21884671 | J Hepatol | Acoustic radiation force-based shear stiffness and non-invasive panels of tests in Japanese patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A45956 | 21875499 | J Hepatol | Touching some firm ground in the epidemiology of NASH. | 2011 | Details |
| A45957 | 21868456 | BMJ | Investigating mixed hyperlipidaemia. | 2011 | Details |
| A45958 | 21860151 | Indian J Dermatol Venereol Leprol | Monitoring methotrexate hepatotoxicity in psoriasis. | 2012 | Details |
| A45959 | 21856859 | J Pharmacol Exp Ther | Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. | 2011 | Details |
| A45960 | 21841000 | J Biol Chem | L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. | 2011 | Details |
| A45961 | 21832111 | J Clin Endocrinol Metab | Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. | 2011 | Details |
| A45962 | 21819679 | Comp Med | The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome. | 2011 | Details |
| A45963 | 21819283 | Expert Opin Pharmacother | Current treatment for nonalcoholic fatty liver disease. | 2011 | Details |
| A45964 | 21818144 | Nat Rev Gastroenterol Hepatol | Clinical trials: Trial design in NASH--realities and challenges. | 2011 | Details |
| A45965 | 21807932 | JPEN J Parenter Enteral Nutr | Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. | 2011 | Details |
| A45966 | 21805747 | Zhonghua Gan Zang Bing Za Zhi | [The relationship between nonalcoholic fatty liver disease and polycystic ovarian syndrome]. | 2011 | Details |
| A45967 | 21793025 | Hepatology | I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population. | 2011 | Details |
| A45968 | 21788578 | Diabetes | The metabolically benign and malignant fatty liver. | 2011 | Details |
| A45969 | 21782772 | Clin Gastroenterol Hepatol | Increased perioperative mortality following bariatric surgery among patients with cirrhosis. | 2011 | Details |
| A45970 | 21775769 | Arterioscler Thromb Vasc Biol | Steatosis DeLIVERs high-sensitivity C-reactive protein. | 2011 | Details |
| A45971 | 21772667 | Mediators Inflamm | Foxp3 expression in liver correlates with the degree but not the cause of inflammation. | 2011 | Details |
| A45972 | 21770296 | Nihon Naika Gakkai Zasshi | [The cutting-edge of medicine; clinical and molecular pathology of type 2 diabetic liver]. | 2011 | Details |
| A45973 | 21768193 | BMJ | Non-alcoholic fatty liver disease in children. | 2011 | Details |
| A45974 | 21768191 | BMJ | How big a problem is non-alcoholic fatty liver disease? | 2011 | Details |
| A45975 | 21767281 | Aliment Pharmacol Ther | Do we need a histological score to diagnose non-alcoholic steatohepatitis? | 2011 | Details |
| A45976 | 21766632 | Nihon Rinsho | [Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD)]. | 2011 | Details |
| A45977 | 21760736 | Diabetes Metab Syndr Obes | Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. | 2011 | Details |
| A45978 | 21742295 | Clin Res Hepatol Gastroenterol | First European Young Hepatologist Workshop: topics and advances. | 2011 | Details |
| A45979 | 21751586 | J Assoc Physicians India | Liver, a window to the heart in type 2 diabetes. | 2011 | Details |
| A45980 | 21750513 | Nat Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way? | 2011 | Details |
| A45981 | 21745295 | Liver Int | Increased liver steatosis in anabolic-androgenic steroid users: more evidence towards toxicant-associated fatty liver disease development. | 2011 | Details |
| A45982 | 21745285 | Liver Int | Dual role of survivin in non-alcoholic fatty liver disease. | 2011 | Details |
| A45983 | 21741924 | J Hepatol | Lipotoxicity in NASH. | 2011 | Details |
| A45984 | 21737970 | Nihon Shokakibyo Gakkai Zasshi | [Recent progress in the research of NASH/NAFLD in Japan]. | 2011 | Details |
| A45985 | 23776795 | Int J Appl Basic Med Res | Eyeing non-alcoholic fatty liver disease: The noninvasive way. | 2011 | Details |
| A45986 | 23016184 | Heart Advis | Exercise benefits people with fatty liver disease and pre-diabetes. Cleveland Clinic study finds that treadmill walking slows the progression of non-alcoholic fatty liver disease and improves your fat-burning ability. | 2011 | Details |
| A45987 | 21713978 | Magn Reson Med | Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method. | 2011 | Details |
| A45988 | 21713308 | Cardiovasc J Afr | Serving diabetes and cardiology: round three of the South African diabetologist/cardiologist debate. | 2011 | Details |
| A45989 | 21710698 | Duke Med Health News | Liver disease on the rise; obesity cited as cause. Weight loss, a healthy diet, and exercise may help prevent non-alcoholic fatty liver disease, a precursor to chronic liver disease. | 2011 | Details |
| A45990 | 21710476 | Hepatology | Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease. | 2011 | Details |
| A45991 | 21708199 | J Hepatol | NASH animal models: are we there yet? | 2011 | Details |
| A45992 | 21704003 | J Hepatol | APOC3 polymorphisms and non-alcoholic fatty liver disease: resolving some doubts and raising others. | 2011 | Details |
| A45993 | 21703167 | J Hepatol | Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease. | 2011 | Details |
| A45994 | 21701901 | Hepatol Int | Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice. | 2011 | Details |
| A45995 | 21699779 | Gastroenterology | Cross β-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions. | 2011 | Details |
| A45996 | 21697185 | Alcohol Alcohol | Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. | 2011 | Details |
| A45997 | 21696523 | Hepatol Res | Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease. | 2011 | Details |
| A45998 | 21683162 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease: what are the odds your patient will get a transplant? | 2011 | Details |
| A45999 | 21661508 | Diabetes Self Manag | High-fructose corn syrup. What's all the fuss about? | 2011 | Details |
| A46000 | 21661045 | Magn Reson Med | On the performance of T2* correction methods for quantification of hepatic fat content. | 2011 | Details |
| A46001 | 21654881 | Am J Transl Res | Lipotoxicity in HepG2 cells triggered by free fatty acids. | 2011 | Details |
| A46002 | 21647651 | Dig Dis Sci | Cryptogenic chronic hepatitis and its changing guise in adults. | 2011 | Details |
| A46003 | 21640324 | Am J Med | Hyperinsulinemia in nonalcoholic fatty liver disease in nondiabetic adults. | 2011 | Details |
| A46004 | 21633779 | Singapore Med J | Haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease: concern on findings. | 2011 | Details |
| A46005 | 21628000 | Clin Gastroenterol Hepatol | Chronic liver disease in the Hispanic population of the United States. | 2011 | Details |
| A46006 | 21618568 | Hepatology | Mortality in nonalcoholic fatty liver disease: clues from the Cremona study. | 2011 | Details |
| A46007 | 21618266 | Hepatology | Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree? | 2011 | Details |
| A46008 | 21604916 | Ann Med | The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk. | 2011 | Details |
| A46009 | 21601719 | Gen Hosp Psychiatry | Prevalence of liver disease in veterans with bipolar disorder or schizophrenia. | 2011 | Details |
| A46010 | 21599573 | Ann Med | Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study. | 2011 | Details |
| A46011 | 21564446 | Int J Clin Pract | Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study. | 2011 | Details |
| A46012 | 21557278 | Hepatology | Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. | 2011 | Details |
| A46013 | 21554270 | Eur J Clin Invest | Role of type 2 diabetes mellitus in nonalcoholic fatty liver disease. | 2011 | Details |
| A46014 | 21525484 | Diabetes Care | Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. | 2011 | Details |
| A46015 | 21538633 | NMR Biomed | Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. | 2011 | Details |
| A46016 | 21538430 | Hepatology | Dietary supplementation with methyl donor groups could prevent nonalcoholic fatty liver. | 2011 | Details |
| A46017 | 21536711 | Endocr Rev | Genetic syndromes of severe insulin resistance. | 2011 | Details |
| A46018 | 21536286 | Atherosclerosis | MicroPPARticle in atherosclerosis: guilty or innocent by-standers? | 2011 | Details |
| A46019 | 21526706 | Clin Med (Lond) | Non-alcoholic fatty liver disease: a massive problem. | 2011 | Details |